HomeNewsIndiaIndia to start drone trials for delivery of food, medicines, vaccines: Check details

India to start drone trials for delivery of food, medicines, vaccines: Check details

A global drone services provider ANRA Technologies will hold experimental deliveries of medicines in collaboration with the Indian Institute of Technology Ropar and with Swiggy for food deliveries.

June 14, 2021 / 09:25 IST
Story continues below Advertisement
Delivery of COVID-19 vaccines by drones is expected to begin, transporting 10,000 vials from a central location to primary health centres nearby (Representational Image)
Delivery of COVID-19 vaccines by drones is expected to begin, transporting 10,000 vials from a central location to primary health centres nearby (Representational Image)

India will carry out the first long-range drone flights for delivery of medicines and food in parts of Karnataka, Tamil Nadu, Rajasthan and Punjab.

The experimental deliveries will be conducted using long-range drones that can fly upto 20 kilometers, a report in The Economic Times said. This will mark the first time for use of such drones as India permits only drone flights within visual line of sight or 450 metres from the operator.

Story continues below Advertisement

A global drone services provider ANRA Technologies will hold experimental deliveries of medicines in collaboration with the Indian Institute of Technology Ropar and with Swiggy for food deliveries, the report added.

Meanwhile, Throttle Aerospace and Daksha Unmanned Systems, in collaboration with Narayana Healthcare, will conduct deliveries of medicines in Gauribidanur in Karnataka and Thiruvalluvar outside Chennai. The pre-trials for the same will be conducted on June 18 and 19 before the formal launch of its experimental flight on June 21, the publication said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show